Radiotherapy of Ductal Carcinoma In Situ

作者: David Krug , Rainer Souchon

DOI: 10.1159/000437452

关键词:

摘要: Ductal carcinoma in situ (DCIS) is a heterogeneous disease both its biology and clinical course. In the past, recurrence rates after breast-conserving surgery have been as high 30% 10 years. The introduction of mammography screening advances imaging led to an increase detection DCIS. focus this review on role radiotherapy multidisciplinary treatment, including current developments hypofractionation boost delivery, attempts define low-risk subsets DCIS for which need adjuvant radiation repeatedly questioned.

参考文章(38)
Taplin S 299. Lynge E, Ponti A, James T, Májek O, von Euler-Chelpin M, Anttila A, Fitzpatrick P, Frigerio A, Kawai M, Scharpantgen A, Broeders M, Hofvind S, Vidal C, Ederra M, Salas D, Bulliard JL, Tomatis M, Kerlikowske K, ICSN DCIS Working group (it includes Zappa M), None, Variation in detection of ductal carcinoma in situ during screening mammography: A survey within the International Cancer Screening Network European Journal of Cancer. ,vol. 50, pp. 185- 192 ,(2014) , 10.1016/J.EJCA.2013.08.013
Lara Hathout, Tarek Hijal, Valérie Théberge, Bernard Fortin, Horia Vulpe, Jean-Charles Hogue, Christine Lambert, Houda Bahig, Louise Provencher, Peter Vavassis, Michael Yassa, Hypofractionated Radiation Therapy for Breast Ductal Carcinoma In Situ International Journal of Radiation Oncology Biology Physics. ,vol. 87, pp. 1058- 1063 ,(2013) , 10.1016/J.IJROBP.2013.08.026
Raquel Ciervide, Shubhada Dhage, Amber Guth, Richard L. Shapiro, Deborah M. Axelrod, Daniel F. Roses, Silvia C. Formenti, Five Year Outcome of 145 Patients With Ductal Carcinoma In Situ (DCIS) After Accelerated Breast Radiotherapy International Journal of Radiation Oncology*Biology*Physics. ,vol. 83, pp. e159- e164 ,(2012) , 10.1016/J.IJROBP.2011.11.025
F. Sedlmayer, , M.-L. Sautter-Bihl, W. Budach, J. Dunst, G. Fastner, P. Feyer, R. Fietkau, W. Haase, W. Harms, R. Souchon, F. Wenz, R. Sauer, DEGRO practical guidelines: radiotherapy of breast cancer I: radiotherapy following breast conserving therapy for invasive breast cancer. Strahlentherapie Und Onkologie. ,vol. 189, pp. 825- 833 ,(2013) , 10.1007/S00066-013-0437-8
Harry Bartelink, Philippe Maingon, Philip Poortmans, Caroline Weltens, Alain Fourquet, Jos Jager, Dominic Schinagl, Bing Oei, Carla Rodenhuis, Jean-Claude Horiot, Henk Struikmans, Erik Van Limbergen, Youlia Kirova, Paula Elkhuizen, Rudolf Bongartz, Raymond Miralbell, David Morgan, Jean-Bernard Dubois, Vincent Remouchamps, René-Olivier Mirimanoff, Sandra Collette, Laurence Collette, Whole-breast irradiation with or without a boost for patients treated with breast-conserving surgery for early breast cancer: 20-year follow-up of a randomised phase 3 trial Lancet Oncology. ,vol. 16, pp. 47- 56 ,(2015) , 10.1016/S1470-2045(14)71156-8
Melvin J. Silverstein, Michael D. Lagios, Pamela H. Craig, James R. Waisman, Bernard S. Lewinsky, William J. Colburn, David N. Poller, A prognostic index for ductal carcinoma in situ of the breast. Cancer. ,vol. 77, pp. 2267- 2274 ,(1996) , 10.1002/(SICI)1097-0142(19960601)77:11<2267::AID-CNCR13>3.0.CO;2-V
Julia S. Wong, Yu-Hui Chen, Michele A. Gadd, Rebecca Gelman, Susan C. Lester, Stuart J. Schnitt, Dennis C. Sgroi, Barbara J. Silver, Barbara L. Smith, Susan L. Troyan, Jay R. Harris, Eight-year update of a prospective study of wide excision alone for small low- or intermediate-grade ductal carcinoma in situ (DCIS) Breast Cancer Research and Treatment. ,vol. 143, pp. 343- 350 ,(2014) , 10.1007/S10549-013-2813-6
I. Meattini, L. Livi, D. Franceschini, C. Saieva, F. Meacci, L. Marrazzo, B. Bendinelli, V. Scotti, C. De Luca Cardillo, J. Nori, L. Sanchez, L. Orzalesi, P. Bonomo, D. Greto, M. Bucciolini, S. Bianchi, G. Biti, Role of radiotherapy boost in women with ductal carcinoma in situ: A single-center experience in a series of 389 patients Ejso. ,vol. 39, pp. 613- 618 ,(2013) , 10.1016/J.EJSO.2013.03.002